Drawing for ODEXXA

USPTO serial 87253642

ODEXXA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
YARD, JOHN S
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ODEXXA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark Harrison

MARK HARRISON VENABLE LLPPO BOX 34385WASHINGTON, DC 20043-9998UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcoticsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2017MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
May 24, 2017ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
May 24, 2017OP.TOPPOSITION TERMINATED NO. 999999—
May 24, 2017OP.SOPPOSITION SUSTAINED NO. 999999—
Feb 21, 2017OP.IOPPOSITION INSTITUTED NO. 999999—
Feb 21, 2017OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jan 31, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 31, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 11, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 20, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2016DOCKASSIGNED TO EXAMINER—
Dec 6, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 5, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance